-
IntroducedJun 12, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Last Action See all actions
Senate • Jun 12, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary/Bill Text
Comments on S 2062
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jun 12, 2025 | Senate
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Texts
Documents